Bioavailability Study of Propranolol Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions Clinical Trial

Official title:
Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Par Propranolol 160 mg With That of Inderal-LA Propranolol 160 mg in Healthy Subjects Under Fasting Conditions.

Status Completed

Clinical Trial Summary

To compare the single-dose bioavailability of Propranolol 160 Mg ER capsules with Inderal-La

Clinical Trial Description

To compare the single -dose bioavailability of Par Propranolol 160 Mg ER capsules with Wyeth Pharmaceuticals, Inderal-LA, Propranolol under fasting conditions. ;

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label

Related Conditions & MeSH terms

Disease
To Determine Bioequivalence Under Fasting Conditions

Clinical Trial Details

NCT number	NCT00653120
Study type	Interventional
Source	Par Pharmaceutical, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	May 2005
Completion date	November 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00653380` - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting Conditions	Phase 1
Completed	`NCT00653315` - Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions	Phase 1
Completed	`NCT00652912` - Bioavailability Study of Clonazepam ODT Under Fasting Conditions	Phase 1
Completed	`NCT00653419` - Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions	Phase 1
Completed	`NCT00652795` - Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions	Phase 1
Completed	`NCT01380457` - Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions	Phase 1
Completed	`NCT01380483` - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions	Phase 1
Completed	`NCT00652639` - Bioavailability Study of Clonazepam Tablets Under Fasting Conditions	Phase 1
Completed	`NCT00653055` - Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions	Phase 1
Completed	`NCT00653549` - Bioavailability Study of Torsemide Tablets Under Fasting Conditions	Phase 1